PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 10, 1983New England Journal of Medicine143 citations

Long-Term Survival in Multiple Myeloma

View Full Paper
RKRobert A. Kyle

Key Points

Key points are not available for this paper at this time.

Abstract

Despite the use of alkylating agents, patients with multiple myeloma have a median survival period of only two to three years.1 , 2 No series of patients with multiple myeloma surviving for more than 10 years has been reported. This review of such a group was undertaken in an effort to identify the clinical or laboratory features that suggest long-term survival. My colleagues and I found that the response to chemotherapy was the most important factor in recognizing long-term survivors.MethodsThe records of all Mayo Clinic patients given a diagnosis of multiple myeloma between January 1, 1960, and December 31, 1971 . . .

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Robert A. Kyle (1983) studied this question.

synapsesocial.com/papers/6a0ceab2edb32e8d90026718https://doi.org/10.1056/nejm198302103080604
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Twenty Years Follow-Up in a Patient with Multiple Myeloma2009 · 6 citations
  2. 2Prognosis of Myelomatosis on Treatment with Prednisone and Cytostatics1973 · 32 citations
  3. 3Epibulbar IgA Plasmacytoma Occurring in Multiple Myeloma1982 · 30 citations
  4. 4Multiple myeloma; a review of 26 cases.1957 · 682 citations
  5. 5Multiple Myeloma1979 · 26 citations